Abstract
Coronary occlusive disease is the leading cause of death in industrial nations and affects one in four adults. Although heart attacks are caused by occlusion of a coronary artery, some patients have occlusions without infarction because they have sufficient collateral vessels providing an alternate pathway for blood supply. Vascular endothelial growth factor (VEGF) is an angiogenic peptide that can stimulate collateral vessel development in the ischaemic myocardium1–6. We used magnetic resonance imaging (MRI) and image processing to identify and quantify non–invasively the benefits related to VEGF infusion on collateral development in the heart. This was accomplished as a placebo–controlled study in the porcine model of chronic ischaemia7,8 that most closely mimics the human pathophysiology of progressive coronary occlusion9. Image series converted to a space–time map demonstrated that with treatment the ischaemic zone was smaller and the contrast arrival delay was less, which resulted in better ejection fraction and regional wall thickening. These findings demonstrate in a manner applicable to humans, that VEGF improves collateral blood supply, resulting in improved cardiac global and regional function after and in spite of coronary artery occlusion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
Ladoux, A. & Frelin, C. Hypoxia is a strong inducer of vascular endothelial growth factor MRINA expression in the heart. Biochem. biophys. Res. Commun. 195, 1005–1010 (1993).
Banai, S. et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183–2189 (1994).
Takeshita, S. et al. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. clin. Invest. 93, 662–67010 (1994).
Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H. & Keshet, E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. clin. Invest. 91, 2235–2243 (1993).
Jakeman, L.B., Armanini, M., Phillips, H.S. & Ferrara, N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133, 848–859 (1993).
Harada, K. et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. clin. Invest. 94, 623–630 (1994).
Roth, D.M. et al. Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium. Am. J. Physiol. 253, H1279–H1288 (1987).
White, F.C., Roth, D.M. & Bloor, C.M. The pig as a model for myocardial ischemia and exercise. Lab. Anim. Sci. 36, 351–356 (1986).
Burstein, D., Taratuta, E. & Manning, W.J. Factors in myocardial “perfusion” imaging with ultrafast MRI and Gd-DTPA administration. Magn. Reson. Med. 20, 299–305 (1991).
Le Bihan, D. Magnetic resonance imaging of perfusion. Magn. Reson. Med. 14, 283–292 (1990).
Rosen, B., Belliveau, J.W., Vevea, J.M. & Brady, T.J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14, 249–265 (1990).
Atkinson, D., Burstein, D. & Edelman, R.R. First-pass cardiac perfusion: Evaluation with ultrafast MR imaging. Radiology 174, 757–762 (1990).
van Rugge, F.P. et al. Cardiac first-pass myocardial perfusion in normal subjects assessed by sub-second Gd-DPTA enhanced MR imaging. J. Comput. Assisted Tomogr. 15, 959–965 (1991).
Schaefer, S., Tyen, R. & Saloner, D. Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Radiology 185, 795–801 (1992).
Wendland, M.F. et al. Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection. Radiology 186, 535–542 (1993).
Pearlman, J.D. et al. Quantitative real-time dose response of the heart to magnetic contrast agents: Evidence for linear regime (abstract). Proc. Soc. Magn. Reson. Med. 2, 780 (1991).
Laub, G. Breath-hold cine-MR imaging with a shared and reordered gradient echo technique (abstract). Proc. Soc. Magn. Reson. Med. 1, 478 (1993).
Chuang, M. & Pearlman, J.D. Accurate model-independent determination of cardiac volumes. Computer Applications to Assist Radiology, Proceedings of S/CAR-94 (Symposia Foundation, Carlsbad, California, 1994).
Pearlman, J.D., Hogan, R.D., Wiske, P.S., Franklin, T.D. & Weyman, A.E. Echocardiographic definition of the left ventricular centroid. I. Analysis of methods for centroid calculation from a single tomogram. J. Am. Coll. Cardiol. 16(4), 986–92 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pearlman, J., Hibberd, M., Chuang, M. et al. Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis. Nat Med 1, 1085–1089 (1995). https://doi.org/10.1038/nm1095-1085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1095-1085
This article is cited by
-
Development of a potency assay for CD34+ cell-based therapy
Scientific Reports (2023)
-
Biology and therapeutic targeting of vascular endothelial growth factor A
Nature Reviews Molecular Cell Biology (2023)
-
Transcription factor Foxp1 stimulates angiogenesis in adult rats after myocardial infarction
Cell Death Discovery (2022)
-
Perinatal angiogenesis from pre-existing coronary vessels via DLL4–NOTCH1 signalling
Nature Cell Biology (2021)
-
PTEN inhibitor improves vascular remodeling and cardiac function after myocardial infarction through PI3k/Akt/VEGF signaling pathway
Molecular Medicine (2020)